Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Pentraxins and Fc Receptor-Mediated Immune Responses.

Lu J, Mold C, Du Clos TW, Sun PD.

Front Immunol. 2018 Nov 13;9:2607. doi: 10.3389/fimmu.2018.02607. eCollection 2018. Review.

2.

Pentraxins and IgA share a binding hot-spot on FcαRI.

Lu J, Marjon KD, Mold C, Marnell L, Du Clos TW, Sun P.

Protein Sci. 2014 Apr;23(4):378-86. doi: 10.1002/pro.2419. Epub 2014 Jan 28.

3.

Pentraxins: structure, function, and role in inflammation.

Du Clos TW.

ISRN Inflamm. 2013 Sep 14;2013:379040. doi: 10.1155/2013/379040. Review.

4.

C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.

Mold C, Clos TW.

Arthritis Rheum. 2013 Jul;65(7):1891-901. doi: 10.1002/art.37968.

5.

Transforming growth factor-β, macrophage colony-stimulating factor and C-reactive protein levels correlate with CD14(high)CD16+ monocyte induction and activation in trauma patients.

West SD, Goldberg D, Ziegler A, Krencicki M, Du Clos TW, Mold C.

PLoS One. 2012;7(12):e52406. doi: 10.1371/journal.pone.0052406. Epub 2012 Dec 28.

6.

Pentraxins and Fc receptors.

Lu J, Marjon KD, Mold C, Du Clos TW, Sun PD.

Immunol Rev. 2012 Nov;250(1):230-8. doi: 10.1111/j.1600-065X.2012.01162.x. Review.

7.

Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein.

Lu J, Marjon KD, Marnell LL, Wang R, Mold C, Du Clos TW, Sun P.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4974-9. doi: 10.1073/pnas.1018369108. Epub 2011 Mar 7.

8.

Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.

Du Clos TW, Mold C.

Curr Opin Organ Transplant. 2011 Feb;16(1):15-20. doi: 10.1097/MOT.0b013e32834253c7. Review.

9.

Macrophages activated by C-reactive protein through Fc gamma RI transfer suppression of immune thrombocytopenia.

Marjon KD, Marnell LL, Mold C, Du Clos TW.

J Immunol. 2009 Feb 1;182(3):1397-403.

10.

Structural recognition and functional activation of FcgammaR by innate pentraxins.

Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD.

Nature. 2008 Dec 18;456(7224):989-92. doi: 10.1038/nature07468. Epub 2008 Nov 16.

11.

C-reactive protein at the interface between innate immunity and inflammation.

Peisajovich A, Marnell L, Mold C, Du Clos TW.

Expert Rev Clin Immunol. 2008 May;4(3):379-90. doi: 10.1586/1744666X.4.3.379.

PMID:
20476927
12.

C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc gamma R on dendritic cells.

Thomas-Rudolph D, Du Clos TW, Snapper CM, Mold C.

J Immunol. 2007 Jun 1;178(11):7283-91.

13.

C-reactive protein-mediated suppression of nephrotoxic nephritis: role of macrophages, complement, and Fcgamma receptors.

Rodriguez W, Mold C, Kataranovski M, Hutt JA, Marnell LL, Verbeek JS, Du Clos TW.

J Immunol. 2007 Jan 1;178(1):530-8.

14.
16.

Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein.

Rodriguez W, Mold C, Marnell LL, Hutt J, Silverman GJ, Tran D, Du Clos TW.

Arthritis Rheum. 2006 Jan;54(1):325-35.

17.

C-reactive protein: ligands, receptors and role in inflammation.

Marnell L, Mold C, Du Clos TW.

Clin Immunol. 2005 Nov;117(2):104-11. Review.

PMID:
16214080
18.

Analysis of binding sites in human C-reactive protein for Fc{gamma}RI, Fc{gamma}RIIA, and C1q by site-directed mutagenesis.

Bang R, Marnell L, Mold C, Stein MP, Clos KT, Chivington-Buck C, Clos TW.

J Biol Chem. 2005 Jul 1;280(26):25095-102. Epub 2005 May 6.

19.

Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects.

Devaraj S, Du Clos TW, Jialal I.

Arterioscler Thromb Vasc Biol. 2005 Jul;25(7):1359-63. Epub 2005 Apr 28.

PMID:
15860734
20.

Studies of serum C-reactive protein in systemic lupus erythematosus.

Williams RC Jr, Harmon ME, Burlingame R, Du Clos TW.

J Rheumatol. 2005 Mar;32(3):454-61.

PMID:
15742436
21.

Reversal of ongoing proteinuria in autoimmune mice by treatment with C-reactive protein.

Rodriguez W, Mold C, Kataranovski M, Hutt J, Marnell LL, Du Clos TW.

Arthritis Rheum. 2005 Feb;52(2):642-50.

22.

C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity.

Du Clos TW, Mold C.

Immunol Res. 2004;30(3):261-77. Review.

PMID:
15531769
23.

Limited Wegener's granulomatosis presenting with complete heart block.

Ghaussy NO, Du Clos TW, Ashley PA.

Scand J Rheumatol. 2004;33(2):115-8.

PMID:
15163113
24.

C-reactive protein as a regulator of autoimmunity and inflammation.

Du Clos TW.

Arthritis Rheum. 2003 Jun;48(6):1475-7. Review. No abstract available.

25.

C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R.

Mold C, Rodriguez W, Rodic-Polic B, Du Clos TW.

J Immunol. 2002 Dec 15;169(12):7019-25.

26.
28.

The role of C-reactive protein in the resolution of bacterial infection.

Du Clos TW, Mold C.

Curr Opin Infect Dis. 2001 Jun;14(3):289-93. Review.

PMID:
11964845
29.

Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis.

Bharadwaj D, Mold C, Markham E, Du Clos TW.

J Immunol. 2001 Jun 1;166(11):6735-41.

30.

Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs.

Mold C, Gresham HD, Du Clos TW.

J Immunol. 2001 Jan 15;166(2):1200-5.

31.

Function of C-reactive protein.

Du Clos TW.

Ann Med. 2000 May;32(4):274-8. Review.

PMID:
10852144
32.

C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific.

Stein MP, Edberg JC, Kimberly RP, Mangan EK, Bharadwaj D, Mold C, Du Clos TW.

J Clin Invest. 2000 Feb;105(3):369-76.

33.

C-reactive protein binding to murine leukocytes requires Fc gamma receptors.

Stein MP, Mold C, Du Clos TW.

J Immunol. 2000 Feb 1;164(3):1514-20.

34.

The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.

Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW.

J Exp Med. 1999 Aug 16;190(4):585-90.

35.

Chromatin clearance in C57Bl/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells.

Du Clos TW, Volzer MA, Hahn FF, Xiao R, Mold C, Searles RP.

Clin Exp Immunol. 1999 Aug;117(2):403-11.

36.

Regulation of complement activation by C-reactive protein.

Mold C, Gewurz H, Du Clos TW.

Immunopharmacology. 1999 May;42(1-3):23-30. Review.

PMID:
10408362
37.

Inflammatory potential of C-reactive protein complexes compared to immune complexes.

Romero IR, Morris C, Rodriguez M, Du Clos TW, Mold C.

Clin Immunol Immunopathol. 1998 May;87(2):155-62.

PMID:
9614930
38.

Betaxolol and drug-induced lupus complicated by pericarditis and large pericardial effusion.

Hardee JT, Roldan CA, Du Clos TW.

West J Med. 1997 Aug;167(2):106-9. No abstract available.

39.

Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1.

Mold C, Gurulé C, Otero D, Du Clos TW.

Clin Immunol Immunopathol. 1996 Nov;81(2):153-60.

PMID:
8906746
40.

The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice.

Burlingame RW, Volzer MA, Harris J, Du Clos TW.

J Immunol. 1996 Jun 15;156(12):4783-8.

PMID:
8648125
41.
42.

C-reactive protein binds to Fc gamma RI in transfected COS cells.

Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW.

J Immunol. 1995 Aug 15;155(4):2185-93.

PMID:
7636267
43.

Expression and radiolabeling of human C-reactive protein in baculovirus-infected cell lines and Trichoplusia ni larvae.

Marnell L, Mold C, Volzer MA, Burlingame RW, Du Clos TW.

Protein Expr Purif. 1995 Aug;6(4):439-46.

PMID:
8527929
44.

Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome.

Bell SA, Du Clos TW, Khursigara G, Picazo JJ, Rubin RL.

J Autoimmun. 1995 Apr;8(2):293-303.

PMID:
7542004
45.

Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.

Li YP, Mold C, Du Clos TW.

J Immunol. 1994 Mar 15;152(6):2995-3005.

PMID:
8144898
47.

Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive protein.

Du Clos TW, Zlock LT, Hicks PS, Mold C.

Clin Immunol Immunopathol. 1994 Jan;70(1):22-7.

PMID:
8261665
48.

C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding region.

Jewell WS, Marnell LL, Rokeach LA, Du Clos TW.

Mol Immunol. 1993 Jun;30(8):701-8.

PMID:
8502240
49.

Serum amyloid P component binds to histones and activates the classical complement pathway.

Hicks PS, Saunero-Nava L, Du Clos TW, Mold C.

J Immunol. 1992 Dec 1;149(11):3689-94.

PMID:
1431140
50.

Hamster female protein binding to chromatin, histones and DNA.

Saunero-Nava L, Coe JE, Mold C, Du Clos TW.

Mol Immunol. 1992 Jul-Aug;29(7-8):837-45.

PMID:
1378928

Supplemental Content

Support Center